2019
DOI: 10.1016/j.hlc.2018.10.007
|View full text |Cite
|
Sign up to set email alerts
|

Catheter Ablation of VT in Non-Ischaemic Cardiomyopathies: Endocardial, Epicardial and Intramural Approaches

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
15
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 29 publications
(15 citation statements)
references
References 115 publications
0
15
0
Order By: Relevance
“… 8 The other reason is that critical isthmus of re-entry or site of origin in focal arrhythmias may not correlate with the site of the earliest epicardial breakthrough. 9 …”
Section: Discussionmentioning
confidence: 99%
“… 8 The other reason is that critical isthmus of re-entry or site of origin in focal arrhythmias may not correlate with the site of the earliest epicardial breakthrough. 9 …”
Section: Discussionmentioning
confidence: 99%
“…The ability of BPA to reach transmurality might be advantageous while ablating specific VTs, for instance, with a deep origin from LV papillary muscles, IVS, LV midmyocardium or epicardium (as in cases of nonischemic VT) 26 . Since 1996, when Sosa et al 27 described percutaneous access to the pericardial space in patients with chagasic cardiomyopathy, epicardial ablation has been integrated into VT treatment strategies.…”
Section: Discussionmentioning
confidence: 99%
“…Champagne et al reported that lead replacement can correct 77% of the side effects after phrenic nerve irritation [Champagne 2011]. In clinical practice, downregulation of the left ventricular output voltage or multi-polar lead placement may prevent phrenic nerve irritation [Bhaskaran 2019;Ohlow 2013]. In cases II, III, and IV, we adjusted the site of lead implantation, according to our experience with case I.…”
Section: Discussionmentioning
confidence: 99%